Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Return on Invested Capital (2023 - 2025)

Iovance Biotherapeutics (IOVA) has disclosed Return on Invested Capital for 3 consecutive years, with 0.12% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Invested Capital rose 41.0% to 0.12% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.12%, a 41.0% increase, with the full-year FY2025 number at 0.12%, up 49.0% from a year prior.
  • Return on Invested Capital was 0.12% for Q4 2025 at Iovance Biotherapeutics, up from 0.59% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.12% in Q4 2025 to a low of 0.74% in Q1 2024.
  • A 3-year average of 0.55% and a median of 0.56% in 2025 define the central range for Return on Invested Capital.
  • Biggest YoY gain for Return on Invested Capital was 41bps in 2025; the steepest drop was -4bps in 2025.
  • Iovance Biotherapeutics' Return on Invested Capital stood at 0.73% in 2023, then grew by 28bps to 0.53% in 2024, then skyrocketed by 78bps to 0.12% in 2025.
  • Per Business Quant, the three most recent readings for IOVA's Return on Invested Capital are 0.12% (Q4 2025), 0.59% (Q3 2025), and 0.56% (Q2 2025).